Cabot Quarterly Market Report and Teleconference
Quarterly Market Report April 17, 2019: The first quarter of 2019 was as good as the previous one was bad. And that’s not surprising. In fact, in his last quarterly report, Tim concluded by writing, “What the charts signaling...
Read More
Cabot Quarterly Market Report and Teleconference
Quarterly Market Report April 17, 2019: The first quarter of 2019 was as good as the previous one was bad. And that’s not surprising. In fact, in his last quarterly report, Tim concluded by writing, “What the charts signaling...
Read More
Prepare yourself for more ups and downs in our medtech & biotech stocks if this debate heats up. I’m not planning to step out of the space since I think this will pass and we can still do quite well with these types stocks.
...
Read More
Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More
This long-term bond ETF has just hit its buy price.
Read More
The new all time high is a significant milestone. Although the S&P 500 hasn’t hit new highs quite yet it is only just about .01% from the mark. The new high is significant because it negates any possibility that we have been in bear...
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
Cabot Quarterly Market Report and Teleconference
Quarterly Market Report April 17, 2019: The first quarter of 2019 was as good as the previous one was bad. And that’s not surprising. In fact, in his last quarterly report, Tim concluded by writing, “What the charts signaling...
Read More
Cabot Quarterly Market Report and Teleconference
Quarterly Market Report April 17, 2019: The first quarter of 2019 was as good as the previous one was bad. And that’s not surprising. In fact, in his last quarterly report, Tim concluded by writing, “What the charts signaling...
Read More
Small-cap discretionary, energy, financials, industrials, technology and materials are all moving higher. That’s a healthy mix, and it’s helped push the S&P 600 Small Cap Index back up near overhead resistance.
Read More
As we enter the second quarter, emerging markets are on solid footing in a constructive uptrend as EEM remains just above both 50-day and 25-day moving averages. In light of this we are positive and increasing our allocation.
Read More
The tide is changing. The recent perception was that of sputtering economic growth in a market that was panicking about the possibility of a near-term recession. Many of our defensive positions have gone gangbusters in the past turbulent year but I’ll be watching situation...
Read More
Market Views
Bullish, but Cautious
No basic changes for our overall views of a market capable of extending; but just in a guarded way. It measures higher, as its mostly fully-valued for big-cap leaders; hence vulnerable to shakeouts.
Equity markets, the Fed’s calmer monetary policy, generally to...
Read More
The shares of this automotive supplier are trading at a discount. The company has a current annual dividend yield of 6.32%, paid quarterly.
Read More
The market remains strong and I continue to recommend that you be heavily invested in a well-diversified portfolio that meets your investment needs.
Read More
This company is a good buyout candidate. The current annual dividend yield is 1.91%, paid quarterly.
Read More
We’ve Added a New Feature
By request, we have added a new feature to your Cabot Prime Weekly Summary—the Stock Recommendation Tracker. It is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you see...
Read More
We’ve Added a New Feature
By request, we have added a new feature to your Cabot Prime Weekly Summary—the Stock Recommendation Tracker. It is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you see...
Read More
The fund’s annual current dividend yield of 2.35%, paid monthly.
Read More
THE BIG IDEA
What if your doctor had a simple blood test that could predict Alzheimer’s Disease 15 years before any symptoms begin? Would you take it?
How about a test that could predict the likelihood of getting Parkinson’s Disease, multiple sclerosis, and dementia?
Let’s say Miracle...
Read More